Endocrine disruptors and thyroid hormone physiology
Induction and intracellular localization of Nur77 dictate fenretinide-induced apoptosis of human liver cancer cells
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
Synthesis and pharmacological characterization of [125I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor
Effects of AF3442 [ N -(9-ethyl-9 H -carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro
Prostaglandin D2 induces the production of human β-defensin-3 in human keratinocytes
Identification and characterization of small compound inhibitors of human FATP2
Modulation of glucagon-like peptide-1 release by berberine: In vivo and in vitro studies
Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model
Correlation of the time course of development and decay of tolerance to morphine with alterations in sodium pump protein isoform abundance
Investigating the interaction of McN-A-343 with the M2 muscarinic receptor using its nitrogen mustard derivative
A microfluidic hepatic coculture platform for cell-based drug metabolism studies
Human CYP2E1 is regulated by miR-378
Thiopurine S-methyltransferase pharmacogenetics: Functional characterization of a novel rapidly degraded variant allozyme
Nematicidal activity of two monoterpenoids and SER-2 tyramine receptor of Caenorhabditis elegans
Cytosolic NADP+-dependent isocitrate dehydrogenase regulates cadmium-induced apoptosis
Corrigendum to “Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: Analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog” [Biochem. Pharmacol. 77 (2009) 1011-1020],